Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Go back to Novo Nordisk trims price for blockbuster obesity drug as competition heats up| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $43.19 | 52 Week Low | $32.80 | |||
| Day High | $43.19 | P/E | N/A | |||
| Day Low | $43.19 | EPS | $0.00 | |||
| Volume | 181,293 | |||||

